The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Co-distribution agreement with Elemental Machines

11 Mar 2021 07:00

RNS Number : 8628R
DeepMatter Group PLC
11 March 2021
 

11 March 2021

 

DeepMatter Group plc

("DeepMatter", the "Company" or "the Group")

 

DeepMatter signs co-distribution agreement with Elemental Machines

Providing expanded marketing footprint in the US

 

DeepMatter Group plc, the AIM-quoted company focusing on digitising chemistry, is pleased to announce it has signed a co-distribution agreement with Elemental Machines, the US based organisation helping biotechnology and pharmaceutical companies identify research problems through its sensor-based products.

 

This agreement will see Elemental Machines promote DeepMatter's integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware®, to its wide network of small and mid-size biotech North American customers through its sales team, presenting the Group with the opportunity to broaden its customer base and help establish sales opportunities across North America with organisations in the pharmaceutical and biotechnology sectors. DeepMatter will promote Elemental Machines' sensor-based products to its established European network who are interested in a wider sphere of real-time digital inputs for monitoring their laboratory environment, thereby expanding the number of laboratory devices which can integrate with the DigitalGlassware® platform.

 

Founded in 2015 by serial entrepreneur Sridhar Iyengar, Elemental Machines aims to enable reproducibility among the life sciences by using sensory equipment to gather and assess critical variables in the laboratory that can influence the result of an experiment. Their platform empowers LabOps Professionals to proactively run their labs. It currently works with over 200 customers, primarily in North America.

 

Mark Warne, CEO of DeepMatter, commented: "Elemental Machines is an organisation which shares our values of innovation and the pursuit of scientific discovery, and we're pleased to be advancing these with this collaboration. Importantly, this co-distribution agreement provides us with the capability to cast a wider net in North America, and we are very much looking forward to working with Elemental Machines as we capitalise upon this opportunity."

 

Sridhar Iyengar, CEO of Elemental Machines said: "Like Elemental Machines, DeepMatter is another organisation which recognises the enormous potential for the digitisation of chemistry. We believe that DigitalGlassware® is the most effective tool in the market for solving the reproducibility problem and the product offering will resonate well with our customer base.

 

"With both our customers set to benefit from the additional offerings we can now present, I look forward to seeing the difference we can make together in building labs fit for the future."

 

 

For more information, please contact:

DeepMatter Group plc

T: 0141 548 8156

Mark Warne, Chief Executive Officer

 

 

 

 

Canaccord Genuity Limited (Nominated Advisor and Broker)

 

T: 020 7523 8000

Bobbie Hilliam / Angelos Vlatakis

 

 

Alma PR

T: 020 3405 0205

Caroline Forde / Harriet Jackson / Kieran Breheny / Faye Calow

deepmatter@almapr.co.uk

 

 

About DeepMatter Group plc 

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. It has developed and is commercialising data rich platform technologies, including software and laboratory hardware, focused on applications to improve R&D productivity and discovery using Machine Learning / Artificial Intelligence. 

 

DeepMatter's technologies allow chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. They are designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster. 

 

Visit: www.deepmatter.io and follow @deepmattergroup

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAXDEFDLFEFA
Date   Source Headline
14th Jun 20127:00 amRNSBusiness Development Agreement
29th May 20124:03 pmRNSAGM Statement
25th Apr 20127:00 amRNSPreliminary Results - Commercialisation Underway
24th Feb 20127:00 amRNSAnti-Reflective Technology Development
26th Jan 20122:55 pmRNSHolding(s) in Company
3rd Jan 201212:16 pmRNSHolding(s) in Company
17th Oct 20117:00 amRNSAppointment of Chairman
30th Sep 20117:00 amRNSInterim Results
9th Aug 201110:30 amRNSIndustry leading Anti-Reflective Coating
16th Jun 20119:53 amRNSAnnual Financial Report
21st Apr 20117:00 amRNSJapan Agent Appointed
30th Mar 20117:05 amRNSDirectorate Change
30th Mar 20117:00 amRNSAnnual Financial Report
25th Feb 20117:00 amRNSDirectorate Change
27th Jan 201112:44 pmRNSHolding(s) in Company
24th Jan 20111:18 pmRNSHolding(s) in Company
2nd Dec 20107:00 amRNSTrading Update
30th Nov 20107:00 amRNSOAS delivers key process
29th Sep 20107:00 amRNSInterim results
27th Sep 20101:52 pmRNSHolding(s) in Company
14th Jul 201011:23 amRNSHolding(s) in Company
24th Jun 201011:19 amRNSHolding(s) in Company
16th Jun 20104:31 pmRNSHolding(s) in Company
4th Jun 20103:36 pmRNSHolding(s) in Company
2nd Jun 201010:06 amRNSHolding(s) in Company
28th May 20103:14 pmRNSHolding(s) in Company
25th May 20102:26 pmRNSResult of AGM
7th May 201012:49 pmRNSChange of Adviser
28th Apr 20107:00 amRNSFinal Results
16th Feb 20102:55 pmRNSHolding(s) in Company
12th Feb 201012:59 pmRNSHolding(s) in Company
12th Feb 20107:00 amRNSNotification of Interest
9th Feb 20108:58 amRNSDirectorate Change
4th Jan 20107:00 amRNSDirectorate Change
2nd Dec 200910:13 amRNSAward of Options
25th Sep 20097:00 amRNSDirectorate Change and Interim Results
29th May 20093:37 pmRNSAward of Share Options
22nd May 20099:45 amRNSAGM Statement
27th Apr 20097:00 amRNSPreliminary Results
16th Apr 20094:32 pmRNSNotice of AGM
7th Jan 200911:30 amRNSResignation of Director
18th Dec 200810:59 amRNSAward of Share Options
19th Nov 20087:00 amRNSDirectorate Change
11th Nov 20082:48 pmRNSChange of Auditor
30th Oct 20087:00 amRNSHolding(s) in Company
16th Oct 20087:00 amRNSBusiness Update & new Development Agreement signed
15th Oct 20084:34 pmRNSHolding(s) in Company
29th Sep 20087:00 amRNSInterim Results
9th Sep 20081:51 pmRNSHolding(s) in Company
1st Aug 20087:00 amRNSFundraising and Appointment o

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.